World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
23804
World Ranking
1891
National Ranking
76

Medicine

D-Index
76
Citations
23888
World Ranking
18705
National Ranking
691

Steven T. Pals publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Steven T. Pals sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 202 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Steven T. Pals D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Steven T. Pals sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Steven T. Pals is affiliated with the University of Amsterdam in the Netherlands and has made contributions primarily in the field of Medicine, with a focused study in Oncology, Pathology and Forensic Medicine, Immunology, Genetics, and Hematology. Their research encompasses a variety of key topics including Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Proteoglycans and Glycosaminoglycans research, Chemokine receptors and signaling, Immune Cell Function and Interaction, and Cancer Cells and Metastasis.

Among their recent publications are:

  • The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma, 2021, Journal of Hematology & Oncology
  • Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation, 2020, The Journal of Pathology Clinical Research
  • Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  • Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations, 2021, Blood
  • A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies, 2020, Cancer Immunology Research

Their frequent coauthors include:

  • Marcel Spaargaren
  • Marie José Kersten
  • Hildo C. Lantermans
  • Marthe Minderman
  • Annemieke Kuil

Steven T. Pals has published regularly in several venues, particularly:

  • Blood Advances
  • Blood
  • Journal of Hematology & Oncology
  • Blood Cancer Journal
  • Haematologica

Best Publications

  • Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.

    G. Koopman;C. P. M. Reutelingsperger;G. A. M. Kuijten;R. M. J. Keehnen

  • The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

    Marc van de Wetering;Elena Sancho;Cornelis Verweij;Wim de Lau

  • The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

    Martin F. M. de Rooij;Annemieke Kuil;Christian R. Geest;Eric Eldering

  • Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway

    Vera J.M. Wielenga;Ron Smits;Vladimir Korinek;Lia Smit

  • EphB receptor activity suppresses colorectal cancer progression

    Eduard Batlle;Julinor Bacani;Harry Begthel;Suzanne Jonkeer

  • Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases

    Ernst Gleichmann;Steven T. Pals;Anton G. Rolink;Anton G. Rolink;Thadädus Radaszkiewicz;Thadädus Radaszkiewicz

  • The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation

    Kristel Kemper;Martin R. Sprick;Martijn de Bree;Alessandro Scopelliti

  • Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways.

    G. Koopman;H. K. Parmentier;H.-J. Schuurman;W. Newman

  • Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

    Patrick W. B. Derksen;Esther Tjin;Helen P. Meijer;Melanie D. Klok

  • Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

    G Koopman;K H Heider;E Horst;G R Adolf

  • Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients

    Felipe de Sousa E Melo;Selcuk Colak;Joyce Buikhuisen;Jan Koster

  • CD44 splice variants: metastases meet lymphocytes

    Peter Herrlich;Margot Zöller;Steven T. Pals;Helmut Ponta

  • Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells.

    G. Koopman;R. M. J. Keehnen;E. Lindhout;W. Newman

  • Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

    Patrick W. B. Derksen;Robert M. J. Keehnen;Ludo M. Evers;Marinus H. J. van Oers

  • Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion.

    Ramon Arens;Kiki Tesselaar;Paul A Baars;Gijs M.W van Schijndel

  • Bruton's Tyrosine Kinase and Phospholipase Cγ2 Mediate Chemokine-Controlled B Cell Migration and Homing

    David J.J. de Gorter;Esther A. Beuling;Rogier Kersseboom;Sabine Middendorp

  • A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe

    Joppe W R Hovius;Bob de Wever;Maaike Sohne;Matthijs C Brouwer

  • The B Cell Antigen Receptor Controls Integrin Activity through Btk and PLCγ2

    Marcel Spaargaren;Esther A. Beuling;Mette L. Rurup;Helen P. Meijer

  • Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

    Betty Y. Chang;Michelle Francesco;Martin F. M. De Rooij;Padmaja Magadala

  • Signaling through CD44 Is Mediated by Tyrosine Kinases ASSOCIATION WITH p56lck IN T LYMPHOCYTES

    Taher Elamin I. Taher;Linda Smit;Arjan W. Griffioen;Esther J.M. Schilder-Tol

Frequent Co-Authors

Marcel Spaargaren
Marcel Spaargaren University of Amsterdam
Chris J.L.M. Meijer
Chris J.L.M. Meijer Vrije Universiteit Amsterdam
Taco W. Kuijpers
Taco W. Kuijpers University of Amsterdam
Peter Herrlich
Peter Herrlich Leibniz Association
René A. W. van Lier
René A. W. van Lier University of Amsterdam
Sandrine Florquin
Sandrine Florquin University of Amsterdam
Anke van den Berg
Anke van den Berg University Medical Center Groningen
Hans Clevers
Hans Clevers Hubrecht Institute for Developmental Biology and Stem Cell Research
Philip M. Kluin
Philip M. Kluin University Medical Center Groningen
Eric Eldering
Eric Eldering University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related nursing degrees can provide diverse career opportunities in healthcare and research. Bridging from a Family Nurse Practitioner to a more specialized role is now easier with programs like the fnp to acnp bridge program online, offering flexibility for advanced clinical practice.

Accelerated options like the accelerated fnp programs help students fast-track their careers, blending rigorous training with online convenience. For those starting fresh or transitioning from non-nursing backgrounds, some of the best online bsn programs for non nurses offer comprehensive coursework designed to build foundational knowledge efficiently.

Entry into nursing can sometimes present challenges, but there are easiest accelerated nursing programs to get into that provide accessible pathways without compromising quality education. By aligning these educational opportunities with Immunology interests, learners can advance into impactful roles in patient care, clinical trials, and immunotherapy research.

Best Scientists Citing Steven T. Pals

Trending Scientists

Recently Published Articles